Clinical Trials Logo

Clinical Trial Summary

Sudden death from ventricular arrhythmia is a serious and common complication of myocardial infarction, especially with low left ventricular ejection fraction (LVEF). Implantable cardiac defibrillator (ICD) implantation is currently recommended at three months of optimal medical treatment in patients who have had a myocardial infarction and have a LVEF below 35%. This strategy indeed allows a reduction in mortality while early post-infarction implantation showed no benefit in terms of survival. However, the risk of sudden death at this period is the greatest and the temporary defibrillator vest, marketed under the name LifeVest, is now indicated in the early post-infarction period in patients with LVEF less than 35%. Indeed, the LifeVest would allow a reduction in sudden death of rhythmic origin in the first three months post-infarction. No study has yet investigated the prognostic significance of a ventricular rhythm disorder (ventricular tachycardia [VT] or ventricular fibrillation [VF]) occurring during this early and short (approximately 3 months) particular period of wearing the LifeVest: is this a random event, or is it an event predictive of a rhythmic recurrence? The aim of the study is to assess the association between the occurrence of a sustained ventricular rhythm disorder in the early post-infarction period, during the period of wearing the LifeVest (ventricular episodes detected, treated or not), and the risk of rhythmic recurrence at 12 months.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05123885
Study type Observational
Source Central Hospital, Nancy, France
Contact Mathieu ECHIVARD, MD, PhD
Phone + 33383157356
Email [email protected]
Status Not yet recruiting
Start date December 15, 2021
Completion date April 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT00426751 - Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI) Phase 3
Completed NCT00196274 - Autonomic Regulation Trial (ART) N/A
Recruiting NCT04000412 - A Novel Myocardial Impedance Mapping System for Ablation of Post-infarction Ventricular Arrhytmias in Humans
Completed NCT03122210 - Comparaison of 2 SpO2 Level Measured by Pulse Oxymetry in Complications of Acute Coronary Syndrome. N/A
Completed NCT00196261 - Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction N/A
Completed NCT04096079 - Post-ROSC Electrocardiogram After Cardiac arrEst